Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ: VNDA · Real-Time Price · USD

5.35

-0.09 (-1.65%)

At close: Aug 26, 2026, 4:00 PM EDT

5.35

0.00 (0.00%)

After-hours: Aug 26, 2026, 4:14 PM EDT

Vanda Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	215.72	216.11	198.77	192.64	254.38	268.68
Revenue Growth	6.02%	8.72%	3.18%	-24.27%	-5.32%	8.27%
Cost of Revenue	13.51	13.04	11.31	14.8	24.28	25.63
Gross Profit	202.22	203.06	187.46	177.84	230.1	243.05
Selling, General & Admin	263.45	237.95	146.41	112.88	136.49	124.05
Research & Development	116.96	109.27	74.43	76.82	85.77	75.36
Amortization of Goodwill & Intangibles	7.48	7.01	7.27	2.09	1.52	1.48
Operating Expenses	387.89	354.23	228.12	191.8	223.77	200.89
Operating Income	-185.67	-151.17	-40.66	-13.95	6.33	42.17
Interest & Investment Income	6.42	10.47	10.75	-	-	-
Other Non Operating Income (Expenses)	-	-	-	11.49	2.01	1.85
EBT Excluding Unusual Items	-179.25	-140.7	-29.92	-2.46	8.34	44.01
Gain (Loss) on Sale of Investments	2.05	2.05	6.99	8.8	2.96	-1.65
Pretax Income	-177.2	-138.65	-22.92	6.34	11.3	42.36
Income Tax Expense	97.65	81.83	-4.02	3.83	5.03	9.21
Net Income	-274.85	-220.47	-18.9	2.51	6.28	33.15
Net Income to Common	-274.85	-220.47	-18.9	2.51	6.28	33.15
Net Income Growth	-	-	-	-60.02%	-81.07%	42.06%
Shares Outstanding (Basic)	59	59	58	57	56	56
Shares Outstanding (Diluted)	59	59	58	58	57	57
Shares Change	1.60%	1.34%	1.03%	1.01%	0.11%	3.14%
EPS (Basic)	-4.62	-3.74	-0.33	0.04	0.11	0.60
EPS (Diluted)	-4.63	-3.74	-0.33	0.04	0.11	0.58
EPS Growth	-	-	-	-63.64%	-81.03%	38.09%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-143.01	-110.44	-20.48	-88.25	31.31	63.66
Free Cash Flow Per Share	-2.40	-1.87	-0.35	-1.53	0.55	1.12
Gross Margin	93.74%	93.96%	94.31%	92.32%	90.45%	90.46%
Operating Margin	-86.07%	-69.95%	-20.46%	-7.24%	2.49%	15.69%
Profit Margin	-127.41%	-102.02%	-9.51%	1.30%	2.47%	12.34%
Free Cash Flow Margin	-66.29%	-51.11%	-10.30%	-45.81%	12.31%	23.69%
EBITDA	-177.05	-143.06	-32.53	-10.94	9.06	45.01
EBITDA Margin	-82.07%	-66.20%	-16.36%	-5.68%	3.56%	16.75%
D&A For EBITDA	8.62	8.11	8.13	3.01	2.73	2.84
EBIT	-185.67	-151.17	-40.66	-13.95	6.33	42.17
EBIT Margin	-86.07%	-69.95%	-20.46%	-7.24%	2.49%	15.69%
Effective Tax Rate	-	-	-	60.42%	44.47%	21.75%
Revenue as Reported	215.72	216.11	198.77	192.64	254.38	268.68

SEC Filings: 10-K · 10-Q